ID   ZO3_HUMAN               Reviewed;         919 AA.
AC   O95049; A6NFP3; B3KR73; B3KXZ0; B4E2W6; F5H2X0; F5H4S9; K7EK22; Q32N01;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   19-MAR-2014, sequence version 3.
DT   28-JUN-2023, entry version 191.
DE   RecName: Full=Tight junction protein ZO-3;
DE   AltName: Full=Tight junction protein 3;
DE   AltName: Full=Zona occludens protein 3;
DE   AltName: Full=Zonula occludens protein 3;
GN   Name=TJP3; Synonyms=ZO3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RC   TISSUE=Stomach, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT THR-898.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=16129888; DOI=10.1242/jcs.02528;
RA   Michel D., Arsanto J.P., Massey-Harroche D., Beclin C., Wijnholds J.,
RA   Le Bivic A.;
RT   "PATJ connects and stabilizes apical and lateral components of tight
RT   junctions in human intestinal cells.";
RL   J. Cell Sci. 118:4049-4057(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; SER-905 AND SER-906, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [8]
RP   INTERACTION WITH UBN1.
RX   PubMed=18823282; DOI=10.1042/bc20080072;
RA   Aho S., Lupo J., Coly P.-A., Sabine A., Castellazzi M., Morand P.,
RA   Sergeant A., Manet E., Boyer V., Gruffat H.;
RT   "Characterization of the ubinuclein protein as a new member of the nuclear
RT   and adhesion complex components (NACos).";
RL   Biol. Cell 101:319-334(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   INDUCTION.
RX   PubMed=20434232; DOI=10.1016/j.ejcb.2010.03.002;
RA   Vikstroem E., Bui L., Konradsson P., Magnusson K.E.;
RT   "Role of calcium signalling and phosphorylations in disruption of the
RT   epithelial junctions by Pseudomonas aeruginosa quorum sensing molecule.";
RL   Eur. J. Cell Biol. 89:584-597(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164; SER-905 AND SER-906, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CCND1.
RX   PubMed=21411630; DOI=10.1091/mbc.e10-08-0677;
RA   Capaldo C.T., Koch S., Kwon M., Laur O., Parkos C.A., Nusrat A.;
RT   "Tight function zonula occludens-3 regulates cyclin D1-dependent cell
RT   proliferation.";
RL   Mol. Biol. Cell 22:1677-1685(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   INDUCTION.
RX   PubMed=22354024; DOI=10.1128/iai.00001-12;
RA   Kwak Y.K., Vikstroem E., Magnusson K.E., Vecsey-Semjen B.,
RA   Colque-Navarro P., Moellby R.;
RT   "The Staphylococcus aureus alpha-toxin perturbs the barrier function in
RT   Caco-2 epithelial cell monolayers by altering junctional integrity.";
RL   Infect. Immun. 80:1670-1680(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-164; SER-203;
RP   SER-591 AND SER-856, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23608536; DOI=10.1128/mcb.01435-12;
RA   Aschauer L., Gruber L.N., Pfaller W., Limonciel A., Athersuch T.J.,
RA   Cavill R., Khan A., Gstraunthaler G., Grillari J., Grillari R., Hewitt P.,
RA   Leonard M.O., Wilmes A., Jennings P.;
RT   "Delineation of the key aspects in the regulation of epithelial monolayer
RT   formation.";
RL   Mol. Cell. Biol. 33:2535-2550(2013).
RN   [17]
RP   INDUCTION.
RX   PubMed=24314862; DOI=10.1016/j.jnutbio.2013.08.011;
RA   Kim C.Y., Kim K.H.;
RT   "Curcumin prevents leptin-induced tight junction dysfunction in intestinal
RT   Caco-2 BBe cells.";
RL   J. Nutr. Biochem. 25:26-35(2014).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136; SER-319; THR-325;
RP   SER-327; SER-371; SER-591 AND SER-906, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 475-775.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the SH3-kinase fragment of tight junction protein 3
RT   (TJP3) in apo-form.";
RL   Submitted (NOV-2009) to the PDB data bank.
CC   -!- FUNCTION: TJP1, TJP2, and TJP3 are closely related scaffolding proteins
CC       that link tight junction (TJ) transmembrane proteins such as claudins,
CC       junctional adhesion molecules, and occludin to the actin cytoskeleton
CC       (PubMed:16129888). The tight junction acts to limit movement of
CC       substances through the paracellular space and as a boundary between the
CC       compositionally distinct apical and basolateral plasma membrane domains
CC       of epithelial and endothelial cells. Binds and recruits PATJ to tight
CC       junctions where it connects and stabilizes apical and lateral
CC       components of tight junctions (PubMed:16129888). Promotes cell-cycle
CC       progression through the sequestration of cyclin D1 (CCND1) at tight
CC       junctions during mitosis which prevents CCND1 degradation during M-
CC       phase and enables S-phase transition (PubMed:21411630). With TJP1 and
CC       TJP2, participates in the junctional retention and stability of the
CC       transcription factor DBPA, but is not involved in its shuttling to the
CC       nucleus (By similarity). Contrary to TJP2, TJP3 is dispensable for
CC       individual viability, embryonic development, epithelial
CC       differentiation, and the establishment of TJs, at least in the
CC       laboratory environment (By similarity). {ECO:0000250|UniProtKB:O62683,
CC       ECO:0000250|UniProtKB:Q9QXY1, ECO:0000269|PubMed:16129888,
CC       ECO:0000269|PubMed:21411630}.
CC   -!- SUBUNIT: Interacts with occludin OCLN, claudins and TPJ1 (By
CC       similarity). Interacts with PATJ (By similarity). Interacts with UBN1
CC       (PubMed:20434232). Interacts with FASLG (PubMed:19807924). Interacts
CC       with CCND1 (PubMed:21411630). {ECO:0000250|UniProtKB:O62683,
CC       ECO:0000269|PubMed:18823282, ECO:0000269|PubMed:19807924,
CC       ECO:0000269|PubMed:21411630}.
CC   -!- INTERACTION:
CC       O95049; K9N5R3: E; Xeno; NbExp=2; IntAct=EBI-1171427, EBI-26374535;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21411630};
CC       Peripheral membrane protein {ECO:0000269|PubMed:21411630}; Cytoplasmic
CC       side {ECO:0000269|PubMed:21411630}. Cell junction, tight junction
CC       {ECO:0000269|PubMed:21411630, ECO:0000269|PubMed:23608536}. Nucleus
CC       {ECO:0000269|PubMed:23608536}. Note=Exhibits predominant nuclear
CC       expression in proliferating cells but is exclusively junctionally
CC       expressed after confluence is reached (PubMed:23608536). Shows an
CC       epithelial-specific tight junction localization in a TJP1/TJP2-
CC       dependent fashion (By similarity). {ECO:0000250|UniProtKB:Q9QXY1,
CC       ECO:0000269|PubMed:23608536}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=5;
CC         IsoId=O95049-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=O95049-3; Sequence=VSP_040238;
CC       Name=4;
CC         IsoId=O95049-4; Sequence=VSP_047022;
CC       Name=6;
CC         IsoId=O95049-5; Sequence=VSP_053844;
CC   -!- INDUCTION: Exhibits enhanced expression in matured epithelial layers
CC       (PubMed:23608536). Apical leptin, Staphylococcus aureus alpha-toxin and
CC       Pseudomonas aeruginosa acyl-homoserine lactone 3O-C12-HSl lower
CC       expression levels, altering junctional integrity in intestinal cells
CC       (PubMed:20434232, PubMed:22354024, PubMed:24314862).
CC       {ECO:0000269|PubMed:20434232, ECO:0000269|PubMed:22354024,
CC       ECO:0000269|PubMed:23608536, ECO:0000269|PubMed:24314862}.
CC   -!- PTM: Phosphorylated (By similarity). {ECO:0000250|UniProtKB:O62683}.
CC   -!- SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72274.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=EAW69293.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091118; BAG52285.1; -; mRNA.
DR   EMBL; AK128237; BAG54652.1; -; mRNA.
DR   EMBL; AK304462; BAG65278.1; -; mRNA.
DR   EMBL; AC005954; AAC72274.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC006125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW69293.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC108906; AAI08907.1; -; mRNA.
DR   CCDS; CCDS32873.2; -. [O95049-1]
DR   CCDS; CCDS59332.1; -. [O95049-4]
DR   RefSeq; NP_001254489.1; NM_001267560.1. [O95049-1]
DR   RefSeq; NP_001254490.1; NM_001267561.1. [O95049-4]
DR   PDB; 3KFV; X-ray; 2.80 A; A=475-775.
DR   PDBsum; 3KFV; -.
DR   AlphaFoldDB; O95049; -.
DR   SMR; O95049; -.
DR   BioGRID; 118025; 19.
DR   IntAct; O95049; 6.
DR   MINT; O95049; -.
DR   STRING; 9606.ENSP00000465419; -.
DR   TCDB; 8.A.24.1.13; the ezrin/radixin/moesin-binding phosphoprotein 50 (ebp50) family.
DR   GlyCosmos; O95049; 1 site, 1 glycan.
DR   GlyGen; O95049; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O95049; -.
DR   PhosphoSitePlus; O95049; -.
DR   BioMuta; TJP3; -.
DR   EPD; O95049; -.
DR   jPOST; O95049; -.
DR   MassIVE; O95049; -.
DR   MaxQB; O95049; -.
DR   PaxDb; O95049; -.
DR   PeptideAtlas; O95049; -.
DR   ProteomicsDB; 26098; -.
DR   ProteomicsDB; 26665; -.
DR   ProteomicsDB; 50630; -. [O95049-1]
DR   ProteomicsDB; 50632; -. [O95049-3]
DR   Antibodypedia; 23311; 227 antibodies from 33 providers.
DR   DNASU; 27134; -.
DR   Ensembl; ENST00000539908.6; ENSP00000439991.1; ENSG00000105289.15. [O95049-5]
DR   Ensembl; ENST00000541714.7; ENSP00000439278.1; ENSG00000105289.15. [O95049-1]
DR   Ensembl; ENST00000587686.1; ENSP00000467864.1; ENSG00000105289.15. [O95049-3]
DR   Ensembl; ENST00000589378.5; ENSP00000465419.1; ENSG00000105289.15. [O95049-4]
DR   GeneID; 27134; -.
DR   KEGG; hsa:27134; -.
DR   MANE-Select; ENST00000541714.7; ENSP00000439278.1; NM_001267560.2; NP_001254489.1.
DR   UCSC; uc010xhs.4; human. [O95049-1]
DR   AGR; HGNC:11829; -.
DR   CTD; 27134; -.
DR   DisGeNET; 27134; -.
DR   GeneCards; TJP3; -.
DR   HGNC; HGNC:11829; TJP3.
DR   HPA; ENSG00000105289; Tissue enhanced (intestine, stomach).
DR   MIM; 612689; gene.
DR   neXtProt; NX_O95049; -.
DR   OpenTargets; ENSG00000105289; -.
DR   PharmGKB; PA36534; -.
DR   VEuPathDB; HostDB:ENSG00000105289; -.
DR   eggNOG; KOG3580; Eukaryota.
DR   GeneTree; ENSGT00940000160036; -.
DR   HOGENOM; CLU_006234_0_0_1; -.
DR   InParanoid; O95049; -.
DR   OMA; MEEVTIW; -.
DR   OrthoDB; 2904077at2759; -.
DR   TreeFam; TF315606; -.
DR   PathwayCommons; O95049; -.
DR   SignaLink; O95049; -.
DR   BioGRID-ORCS; 27134; 24 hits in 1144 CRISPR screens.
DR   ChiTaRS; TJP3; human.
DR   EvolutionaryTrace; O95049; -.
DR   GeneWiki; TJP3; -.
DR   GenomeRNAi; 27134; -.
DR   Pharos; O95049; Tbio.
DR   PRO; PR:O95049; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O95049; protein.
DR   Bgee; ENSG00000105289; Expressed in mucosa of transverse colon and 165 other tissues.
DR   ExpressionAtlas; O95049; baseline and differential.
DR   Genevisible; O95049; HS.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0045216; P:cell-cell junction organization; IBA:GO_Central.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; IBA:GO_Central.
DR   GO; GO:0035633; P:maintenance of blood-brain barrier; NAS:ARUK-UCL.
DR   GO; GO:1905605; P:positive regulation of blood-brain barrier permeability; IBA:GO_Central.
DR   GO; GO:0150105; P:protein localization to cell-cell junction; IBA:GO_Central.
DR   CDD; cd00992; PDZ_signaling; 3.
DR   CDD; cd12028; SH3_ZO-3; 1.
DR   Gene3D; 2.30.42.10; -; 3.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR008144; Guanylate_kin-like_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR005417; ZO.
DR   InterPro; IPR005420; ZO-3.
DR   PANTHER; PTHR13865; TIGHT JUNCTION PROTEIN; 1.
DR   PANTHER; PTHR13865:SF11; TIGHT JUNCTION PROTEIN ZO-3; 1.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF00595; PDZ; 3.
DR   Pfam; PF07653; SH3_2; 1.
DR   PRINTS; PR01597; ZONOCCLUDNS.
DR   PRINTS; PR01600; ZONOCCLUDNS3.
DR   SMART; SM00072; GuKc; 1.
DR   SMART; SM00228; PDZ; 3.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 3.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS50052; GUANYLATE_KINASE_2; 1.
DR   PROSITE; PS50106; PDZ; 3.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; SH3 domain;
KW   Tight junction.
FT   CHAIN           1..919
FT                   /note="Tight junction protein ZO-3"
FT                   /id="PRO_0000094546"
FT   DOMAIN          11..93
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          195..272
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          380..446
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          475..549
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          580..761
FT                   /note="Guanylate kinase-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100"
FT   REGION          92..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          279..377
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          791..886
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          899..919
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        108..129
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        281..302
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        330..359
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         136
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXY1"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         325
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         591
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         856
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         905
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         906
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..36
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053844"
FT   VAR_SEQ         1
FT                   /note="M -> MNLCGLMPIFPAPLDQVADM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040238"
FT   VAR_SEQ         1
FT                   /note="M -> MAVRFQVADM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047022"
FT   VARIANT         898
FT                   /note="M -> T (in dbSNP:rs1046268)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_056114"
FT   CONFLICT        19
FT                   /note="R -> H (in Ref. 4; AAI08907)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        96
FT                   /note="H -> L (in Ref. 1; BAG52285)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        449
FT                   /note="L -> P (in Ref. 1; BAG54652)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        802
FT                   /note="R -> H (in Ref. 1; BAG52285)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        901
FT                   /note="H -> R (in Ref. 1; BAG52285)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        917
FT                   /note="T -> M (in Ref. 1; BAG65278)"
FT                   /evidence="ECO:0000305"
FT   STRAND          478..482
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          490..493
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          501..506
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          522..527
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          533..539
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           542..555
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           596..602
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          606..614
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          621..625
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           628..638
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   TURN            640..642
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          643..645
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           661..669
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          673..676
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           680..688
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          694..701
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           703..713
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           721..735
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           736..738
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          740..745
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          747..749
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   HELIX           751..763
FT                   /evidence="ECO:0007829|PDB:3KFV"
FT   STRAND          766..771
FT                   /evidence="ECO:0007829|PDB:3KFV"
SQ   SEQUENCE   919 AA;  101397 MW;  D36EB684E7E4A6C8 CRC64;
     MEELTIWEQH TATLSKDPRR GFGIAISGGR DRPGGSMVVS DVVPGGPAEG RLQTGDHIVM
     VNGVSMENAT SAFAIQILKT CTKMANITVK RPRRIHLPAT KASPSSPGRQ DSDEDDGPQR
     VEEVDQGRGY DGDSSSGSGR SWDERSRRPR PGRRGRAGSH GRRSPGGGSE ANGLALVSGF
     KRLPRQDVQM KPVKSVLVKR RDSEEFGVKL GSQIFIKHIT DSGLAARHRG LQEGDLILQI
     NGVSSQNLSL NDTRRLIEKS EGKLSLLVLR DRGQFLVNIP PAVSDSDSSP LEDISDLASE
     LSQAPPSHIP PPPRHAQRSP EASQTDSPVE SPRLRRESSV DSRTISEPDE QRSELPRESS
     YDIYRVPSSQ SMEDRGYSPD TRVVRFLKGK SIGLRLAGGN DVGIFVSGVQ AGSPADGQGI
     QEGDQILQVN DVPFQNLTRE EAVQFLLGLP PGEEMELVTQ RKQDIFWKMV QSRVGDSFYI
     RTHFELEPSP PSGLGFTRGD VFHVLDTLHP GPGQSHARGG HWLAVRMGRD LREQERGIIP
     NQSRAEQLAS LEAAQRAVGV GPGSSAGSNA RAEFWRLRGL RRGAKKTTQR SREDLSALTR
     QGRYPPYERV VLREASFKRP VVILGPVADI AMQKLTAEMP DQFEIAETVS RTDSPSKIIK
     LDTVRVIAEK DKHALLDVTP SAIERLNYVQ YYPIVVFFIP ESRPALKALR QWLAPASRRS
     TRRLYAQAQK LRKHSSHLFT ATIPLNGTSD TWYQELKAII REQQTRPIWT AEDQLDGSLE
     DNLDLPHHGL ADSSADLSCD SRVNSDYETD GEGGAYTDGE GYTDGEGGPY TDVDDEPPAP
     ALARSSEPVQ ADESQSPRDR GRISAHQGAQ VDSRHPQGQW RQDSMRTYER EALKKKFMRV
     HDAESSDEDG YDWGPATDL
//
